In view of these problems, one study found that nuclear factor erythroid 2-related factor 2 (NRF2) activators protect kidney function by reducing oxidative stress, suggesting that reducing oxidative stress is a key factor in the treatment of kidney diseases [14]. Here, NFE2L2 is linked to kidney disorder.